Media Highlights

Cloud computing support accelerates COVID-19 vaccine improvements

Cloud computing support accelerates COVID-19 vaccine improvements

For the last 11 months, UBC biochemistry and molecular biology professor Prof. Leonard Foster and his team have been studying how SARS-CoV-2 – the virus responsible for COVID-19 – attacks the human body, in hopes of developing a more targeted vaccine with fewer side effects.

New algorithm can identify cells that humans can’t

New algorithm can identify cells that humans can’t

Researchers at the University of British Columbia have developed an algorithm that can accurately identify different types of cells pictured in microscope photos, even when those cells are indistinguishable to the human eye.

Joining forces to improve blood research in Canada

Joining forces to improve blood research in Canada

Partnership with Canadian Blood Services and UBC’s Centre for Blood Research helps train the next generation of blood scientists.

Fast and Furious: Targeting “nitro(gen) boosts” in a deadly bacterium for next-generation antimicrobials

Fast and Furious: Targeting “nitro(gen) boosts” in a deadly bacterium for next-generation antimicrobials

What if bacteria also had the ability to use nitrogen for a “boost”? Alford et al. recently examined the role of a two-component system called NtrBC in Pseudomonas aeruginosa.

Identifying Patients At Risk of Severe Complications Using Sequencing Technology

Identifying Patients At Risk of Severe Complications Using Sequencing Technology

Dr. Bob Hancock, UBC Killam professor, will use genomic methods to identify which patients with COVID-19 are at higher risk of developing life-threatening sepsis.

Anticoagulant RNA-Based Therapies For SARS-CoV-2 Related Thrombosis

Anticoagulant RNA-Based Therapies For SARS-CoV-2 Related Thrombosis

SARS-CoV-2 leads to hyper-coagulability of blood and deadly blood clots (thrombosis).